Epilepsy Drug Recalled Due to Empty Capsules
A drug therapy for epilepsy and shingles pain is being voluntarily recalled by its manufacturer due to complaints of empty capsules.
A drug therapy for epilepsy and shingles pain is being voluntarily recalled by its manufacturer due to complaints of empty capsules.
The empty capsules of gabapentin could result in a reduction in efficacy, short-term withdrawal, or long-period seizures, which could be life-threatening, according to an FDA MedWatch alert.
Aurobindo Pharma USA announced it would recall lot GESB14011-A of gabapentin capsules, USP 300 mg 100-count bottles because of the error. The bottles have an expiration date of December 2015 and were distributed through the Northstar label to retail outlets across the nation.
Consumers with questions can contact Aurobindo Pharma USA Pharmacovigilence group at 732-839-9400, option 2.
In addition, anyone who has experienced an adverse reaction to the products can report it to the FDA’s MedWatch by downloading a form at www.fda.gov/MedWatch/getforms.htm and submitting it online, or by requesting the form by phone at 1-800-332-1088 and mailing it in or submitting it via fax to 1-800-FDA-0178.
